Product Information
DIOVAN HCT 80-12.5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $10.5648 per EA under NDC 00078031434. Its NADAC has been published 401 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the valsartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 80 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078031434
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/7/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
New Drug (NDA)
FDA Application
NDA020818On Market Since
3/6/1998
Pharmacological Classes
Price Statistics
The NADAC for DIOVAN HCT 80-12.5 MG TABLET has been published 401 times since Nov 28, 2013, and over the history we have for it it has risen 169.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.5648 per EA |
|---|---|
| All-time high | $10.5648 (Jun 24, 2026) |
| All-time low | $3.9142 (Nov 28, 2013) |
| 52-week high | $10.5648 |
| 52-week low | $10.2571 |
| Median price | $7.3876 |
| Average price | $7.4294 |
| Largest weekly change | +17.2% (Dec 18, 2024) |
| Weeks tracked | 401 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIOVAN HCT 80-12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIOVAN HCT 80-12.5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $10.5648 per EA (NDC 00078031434), effective Jun 24, 2026.
How has the price of DIOVAN HCT 80-12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIOVAN HCT 80-12.5 MG TABLET has risen 169.9%. It has been tracked across 401 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIOVAN HCT 80-12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for DIOVAN HCT 80-12.5 MG TABLET has ranged from a low of $3.9142 (Nov 28, 2013) to a high of $10.5648 (Jun 24, 2026), with a median of $7.3876 per EA.
Are there cheaper alternatives to DIOVAN HCT 80-12.5 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VALSARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TAB, is $0.1325 per EA — about 99% below DIOVAN HCT 80-12.5 MG TABLET.
Who manufactures DIOVAN HCT 80-12.5 MG TABLET?
DIOVAN HCT 80-12.5 MG TABLET (NDC 00078031434) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification